Vahe Bedian, Director of Oncology External Projects, AstraZeneca Pharmaceuticals
Michael A. Meador, Director, National Nanotechnology Coordination Office
Eugene Seymour, CEO, Nanoviricides, Inc
Guillaume Pfefer, Former President & CEO, Kala Pharmaceuticals
Anne L van de Ven, Assistant Director, CaNCURE
Amir Nashat, Managing Partner, Polaris Partners